INSP
Inspire Medical Systems, Inc.
$50.50
+1.35 (+2.75%)
At close · Jul 15
Market Cap
$1.49B
Shares
28,813,153
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Dana G. Mead, Jr. | Class II director | Appointed | 2026-05-05 |
| Georgia Melenikiotou | Class II director | Appointed | 2026-05-05 |
| Gary L. Ellis | Class II director | Appointed | 2026-05-05 |
Key facts
CIK
1609550
CUSIP
457730109
13F (30d)
29 filings
24 filers
Visit website
Investor relations